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The Rep68 and Rep78 proteins of adeno-associated virus type-2 (AAV) are multifunctional DNA binding proteins which
are involved in the positive and negative regulation of AAV genes, as well as various cellular and heterologous viral genes.
In this study we report that Rep68 enhances expression from the major immediate early promoter (MIEP) of human
cytomegalovirus (HCMV). This Rep-mediated enhancement of RNA levels is abrogated by the introduction of a Rep recogni-
tion sequence (RRS) at either position 018 or 0244 in the HCMV–MIEP. However, a mutant RRS (mRRS), which is not
bound by Rep68 is unable to negate the effect of Rep68. Sequence analysis and electrophoretic mobility shift assays showed
no Rep68 binding sites within the wild-type HCMV–MIEP. Rep68 may therefore be enhancing expression from the HCMV–
MIEP by interacting with other regulatory proteins that have an effect on the expression from this promoter or by altering
the expression of a cellular gene whose product influences the HCMV–MIEP. Our results may also help to explain the
previous observation that coinfection with AAV enhances the cytopathic effect of HCMV. q 1997 Academic Press
INTRODUCTION Muzyczka, 1990; Owens et al., 1993), the p5 promoter of
AAV (McCarty et al., 1994), and the human immunodefi-
Adeno-associated virus type 2 (AAV) is a nonpatho- ciency virus type-1 (HIV-1) long terminal repeat (HIV-LTR)
genic human parvovirus. It requires coinfection with (Batchu and Hermonat, 1995). Over 20 RRSs have been
helper viruses such as adenoviruses or herpesviruses identified within the human genome (Batchu et al., 1994;
for efficient replication and production of viral progeny Weitzman et al., 1994; Wonderling and Owens, 1996,
(Carter, 1990; McPherson et al., 1985). In the absence 1997), including sites within the preferred AAV integration
of helper virus AAV can establish a latent infection by locus in human chromosome 19 (Weitzman et al., 1994),
integrating its genome into the host DNA (Kotin et al., the c-H-ras and c-sis proto-oncogenes (Batchu et al.,
1990). AAV has a linear single-stranded DNA genome. 1994; Wonderling and Owens, 1996), and many other
The left half of the genome codes for the Rep proteins genes known to be involved in cell proliferation (Won-
and the right half codes for the capsid proteins (Carter et derling and Owens, 1997). Rep68 and Rep78 possess a
al., 1990; Hermonat et al., 1984). The larger Rep proteins, site- and strand-specific endonuclease activity (Im and
namely Rep78 and Rep68 are expressed from the p5 Muzyczka, 1990; Snyder et al., 1990) which plays a vital
promoter; whereas the smaller Rep proteins, namely role in the replication and integration of AAV (Linden et
Rep52 and Rep40, are expressed from the p19 promoter al., 1996; Snyder et al., 1990; Urcelay et al., 1995). In
(Mendelson et al., 1986; Srivastava et al., 1983). The cap- addition to endonuclease activity the Rep proteins have
sid proteins, VP-1, VP-2, and VP-3, are expressed from DNA/DNA helicase (Im and Muzyczka, 1990; Im and Mu-
the p40 promoter (Carter et al., 1990). zyczka, 1992), RNA/DNA helicase, and ATPase activities
The Rep proteins of AAV, mainly Rep68 and Rep78, (Wonderling et al., 1995). Rep proteins also have anti-
are multifunctional proteins. Rep78 and/or Rep68 have oncogenic effects which include their ability to inhibit
been shown to bind to Rep recognition sequences (RRSs) cellular transformation by bovine papilloma virus (Hermo-
in the inverted terminal repeats (ITRs) of AAV (Im and nat, 1989) and by adenovirus E1a plus an activated ras
oncogene (Khleif et al., 1991). They also inhibit HIV-1
replication (Antoni et al., 1991; Oelze et al., 1994; Rittner1 Present address: Heska Corp., 1825 Sharp Point Drive, Fort Collins,
et al., 1992).CO 80525.
2 Present address: Genzyme Corp., One Mountain Rd., Framingham, AAV Rep proteins down-regulate gene expression from
MA 01701. the p5 and p19 promoters of AAV (Beaton et al., 1989;3 To whom correspondence and reprint requests should be ad-
Kyo¨stio¨ et al., 1994, 1995). The Rep proteins have alsodressed at Laboratory of Molecular and Cellular Biology, NIDDK, Na-
been shown to repress several heterologous promoterstional Institutes of Health, Bldg. 8, Rm. 309, 8 Center Dr. MSC 0840,
Bethesda, MD 20892-0840. Fax: (301) 402-0053. E-mail: ro6n@nih.gov. such as the human c-fos, c-myc and c-H-ras promoters,
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the HIV-LTR and the upstream regulatory region of hu- AAV, and AAV enhances the cytopathic effect of HCMV
(McPherson et al., 1985).man papilloma virus (HPV URR) (Antoni et al., 1991;
Batchu and Hermonat, 1995; Hermonat, 1991, 1994;
MATERIALS AND METHODSHo¨rer et al., 1995). In the presence of helper adenovirus,
Rep proteins can stimulate expression from the AAV p19 Cells
and p40 promoters (Labow et al., 1986; McCarty et al.,
Adenovirus-transformed human embryonic kidney 2931991; Pereira et al., 1997). We have recently shown that
cells (Graham et al., 1977) were maintained as monolayerRep68 enhances the expression of the human c-sis
cultures and grown in Eagle’s minimal essential mediumproto-oncogene which encodes the B polypeptide of
(Quality Biological Inc., Gaithersburg, MD) supplementedplatelet-derived growth factor (Wonderling and Owens,
with 10% fetal calf serum (Inovar, Gaithersburg, MD), 21996). There appear to be at least two mechanisms for
mM L-glutamine, and 100 U each of penicillin, neomycin,Rep-mediated gene regulation, one which depends on
and streptomycin (Life Technologies Inc., Gaithersburg,stable binding to an RRS and another mechanism which
MD) per milliliter. Cells were grown at 377 in a humidifieddoes not appear to require a stable binding site (Kyo¨stio¨
atmosphere containing 5% CO2 .et al., 1995). For example, in the case of the AAV p5
promoter, when the p5-RRS is mutated to a sequence Plasmids
that no longer binds Rep proteins, Rep-mediated repres-
The AAV plasmids used in this study were constructedsion of transcription from the p5 promoter is not com-
using standard techniques (Sambrook et al., 1989). Plas-pletely lost. Wild-type Rep68 can still partially down-regu-
mids pSK9, pSK9/NTP, pHIVrepamD, and pCATwt760 arelate the p5 promoter, suggesting that there is also an
described in detail elsewhere (Kyo¨stio¨ et al., 1995;RRS-independent mechanism of regulation. However, an
Owens et al., 1993; Stinski and Roehr, 1985). PlasmidNTP binding site mutant form of Rep68 completely loses
pSK9 (Owens et al., 1993) contains the AAV Rep68 codingits ability to down-regulate the p5 promoter (Kyo¨stio¨ et region expressed from the HIV-LTR. Plasmid pHIVrep-al., 1995). These observations lend support to the above-
amD (Kyo¨stio¨ et al., 1995) encodes a truncated dysfunc-mentioned dual mechanism model. Also, heterologous
tional mutant of Rep68 (designated as Repam). Plasmid
promoters, such as the c-fos, c-myc, and HPV-URR pro-
pSK9/NTP (Kyo¨stio¨ et al., 1995) codes for a mutant Rep
moters, that are down-regulated by Rep proteins, do not
protein with a point mutation in the NTP-binding motif
contain an RRS (Hermonat, 1994; Ho¨rer et al., 1995).
(designated as Rep68/K340H).
In order to understand better the role of Rep proteins in Plasmid pCATwt760 (obtained from Dr. M. F. Stinski)
transcriptional regulation, we were looking for a promoter (Stinski and Roehr, 1985) contains the HCMV–MIEP from
that was unaffected by Rep proteins, into which we could 0749 to/7 upstream of the prokaryotic chloramphenicol
introduce an RRS and look for the consequences on acetyltransferase (CAT) gene. This includes the CAAT
transcription from the altered promoter. We chose the box, TATA box, and the cap site for the initiation of tran-
major immediate early promoter of human cytomegalovi- scription (as shown in Fig. 1). Plasmid pCAT/D(0749 to
rus (HCMV–MIEP) (Fig. 1) since other groups have re- 0349) was constructed by digesting pCATwt760 with
ported the HCMV–MIEP to be unaffected by Rep proteins NdeI and then blunt ending the larger fragment with T4
(Heilbronn et al., 1990; Rittner et al., 1992). Since we have DNA polymerase prior to religation. Plasmid pCAT/
demonstrated previously that Rep68 is a more efficient D(0749 to 0244) was constructed by digesting
repressor of the AAV p5 promoter than Rep78 in 293 cells pCATwt760 with SnaBI and NdeI followed by blunting
(Kyo¨stio¨ et al., 1994), we chose to test the effects of and ligation of the larger fragment. Plasmid pCAT/
Rep68 on the HCMV–MIEP with or without an RRS. D(0749 to 0244/D-18 to /7) was made by digesting
HCMV, a member of the herpes family, is a ubiquitous pCAT/D(0749 to 0244) with SacI and HindIII followed
human pathogen that causes, among many other syn- by blunting and ligation of the larger fragment. To intro-
dromes, multiple forms of embryopathies and fetopathies duce an RRS or a mutant RRS (mRRS) at position-18 in
as a consequence of prenatal infection (Stagno et al., the HCMV–MIEP, pCATwt760 was digested with SacI
1982; Weller, 1971). It is increasingly recognized as a and ligated to double-stranded oligonucleotides con-
taining either the RRS or mRRS and SacI overhangs (seecause of severe pneumonitis and septicemia in immuno-
Table 1). To introduce the RRS or mRRS at position 0244compromised individuals such as AIDS patients or can-
in the HCMV–MIEP, pCATwt760 was digested withcer patients undergoing aggressive chemotherapy (Ku¨hn
SnaBI and ligated to double-stranded oligonucleotideset al., 1995; Ratnamohan et al., 1992; Zaia, 1986). HCMV
containing either the RRS or mRRS.has a large linear double-stranded DNA genome of about
235 kb. The replication of the virus and the transcription
DNA transfectionsof the mRNAs which encode its proteins are governed
by a complex network of events involving viral and host Cotransfections were performed using 10 mg of a plas-
mid encoding Rep68 (pSK9), a truncated nonfunctionalfactors (Stinski, 1990). HCMV is a complete helper for
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FIG. 1. HCMV–MIEP–CAT constructs used in this study. The vector sequences have been omitted. The cis repressor signal (crs) element (013
to 01), the TATA box, the enhancer element (0524 to 0118), NF1 binding sites (0730 to 0610), and AP1 binding site (0731 to 0727) are represented
by the closed circle, the inverted triangle, the hatched rectangle, the closed squares, and the open circle, respectively. The repeat sequences are
denoted by the open squares with numbers inside them that refer to their length. The inserted RRS and mRRS are represented by the small closed
rectangles and open rectangles, respectively. The caret indicates the internal deletion of bases 018 through /7 in construct pCAT/D(0749 to
0244/D 0 18 to /7).
mutant of Rep68 (pHIVrepamD) or the NTP binding site tems (Foster City, CA) 381A DNA synthesizer. CAT mes-
sages were quantitated by reverse transcriptase (RT)mutant Rep68/K340H (pSK9/NTP) and 10 mg of one of
the plasmids of the pCAT760 series by the calcium phos- PCR using an RT-PCR kit (Perkin–Elmer, Foster City, CA)
and following the instructions recommended by the man-phate coprecipitation method (Wigler et al., 1978). Human
293 cells were plated on 100-mm-diameter dishes at a ufacturer. Briefly, various amounts of cytoplasmic RNA
isolated from transfected cells were added to reactiondensity of 3 1 106 cells per plate 24 hr prior to transfec-
tion and cells were harvested 48 hr after transfection to mixtures containing 5 mM MgCl2 , 50 mM KCl, 10 mM
Tris–HCl (pH 8.3), 20 U RNase inhibitor, 2.5 mM randombe used for cytoplasmic RNA isolation (Kyo¨stio¨ et al.,
1994). deoxyribonucleotide hexamers, 1 mM dNTPs, 1 1 10018
mole of CAT-mimic cRNA, and 50 U MuLV reverse tran-
Plasmid uptake determination scriptase (Perkin–Elmer). The samples were incubated
for 15 min at 427 followed by a 5-min incubation at 997.
The nuclei from the same cells used for cytoplasmic PCR reactions contained 3 mM MgCl2 , 50 mM KCl, 10RNA isolation procedures were dissolved in 250 ml of 0.2 mM Tris–HCl (pH 8.3), 0.1 mM each of CAT forward and
M NaOH and boiled for 15 min in order to hydrolyze RNA CAT reverse primer (Table 1), 1 1 106 cpm of 32P-end-
and denature plasmid DNA. The samples were chilled labeled CAT forward primer, 0.2 mM dNTPs, and 2.5 U
and neutralized with an equal volume of 2 M sodium AmpliTaq DNA Polymerase (Perkin–Elmer). The amplifi-
acetate. Serial dilutions of samples were performed in cation profile involved denaturation at 947 for 1 min,
61 SSC (Sambrook et al., 1989) to verify linearity and
primer annealing at 607 for 1 min, and extension at 727C
loaded on a slot blot apparatus (Hybri-Slot Manifold, Life
for 2 min for 30 cycles followed by a final extension step
Technologies Inc.). A 0.7-kb HindIII–ScaI fragment of
at 727 for 7 min. To quantitate b-tubulin messages, the
plasmid pRO5, which contains the CAT gene (Kyo¨stio¨ et
RT-PCR protocol was similar to the one described above
al., 1995), was radiolabeled using the random-primed
except that the forward and reverse primers specific for
DNA labeling kit (Boehringer Mannheim, Indianapolis,
b-tubulin mRNA (Table 1) were used and CAT-mimic
IN) and used to detect cat gene-containing plasmids.
cRNA was omitted from the reaction mixtures.
Primers were labeled with [g-32P]ATP by using poly-RT-PCR assays
nucleotide kinase (New England Biolabs, Beverly, MA)
and unincorporated nucleotides were removed using aThe forward and reverse primers (25-mers) specific for
CAT mRNA were synthesized with an Applied Biosys- Select-D (G-25) spin column (5 Prime-3 Prime, Boulder,
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CO). Forty microliters of the 100-ml RT-PCR reaction sam- mobility shift assays using methods described previously
(Walker et al., 1997; Wonderling and Owens, 1997) withple was analyzed on a 4% polyacrylamide gel. The PCR
products were quantitated by densitometric scanning of both MBP–Rep68D, a maltose binding protein–Rep68
fusion protein (Chiorini et al., 1994), and nuclear extractsthe autoradiograph using a Diversity One densitometer
(Protein and DNA Imageware Systems, Huntington Sta- obtained from 293 cells transfected with plasmids encod-
ing Rep68 (Fig. 2 and data not shown). We could nottion, NY).
detect an RRS in the HCMV–MIEP. To determine the
Production of CAT-mimic cRNA effect of RRSs on Rep-mediated gene regulation, we in-
troduced an RRS at position 018 in the HCMV–MIEP (inPrimary PCR was performed using forward and re-
pCATwt760). This was done by inserting double-strandedverse composite primers (50 mers) whose 5* half was
oligonucleotides with SacI overhangs (shown in Table 1)the same as the CAT-primers but the 3* half was specific
into the SacI site at position 018 (pCAT760/RRS018).for an unrelated DNA (in this case a 377-bp PCR product
Since we did not want to increase the distance betweenproduced by RT-PCR using primers specific for b-tubulin
the TATA box and transcription start site too much bymRNA) (See Table 1). Secondary PCR was performed
inserting the complete p5 RRS, as seen in Fig. 3, theusing a small amount of the primary PCR product and
sequence of the resultant RRS at position 018 is slightlyCAT primers. The product of the secondary PCR was gel-
different from the p5 RRS. We also made another con-purified and blunt-end cloned into SmaI-digested
struct wherein we introduced an mRRS at position 018pSP64Poly(A) (Promega, Madison, WI) to produce the
(pCAT760/mRRS018) the sequence of which is shownplasmid pCAT-mimic. CAT-mimic cRNA was produced
in Fig. 3. An RRS identical to the p5 RRS and an mRRSby in vitro transcription of EcoRI-digested pCAT-mimic
sequence were also introduced at position 0244 in theand SP6 polymerase, using the protocol recommended
HCMV–MIEP. We performed electrophoretic mobilityby the manufacturer (Promega). To each RT-PCR reac-
shift assays to determine if Rep proteins would bind totion, 1 1 10018 mole of CAT-mimic cRNA was added to
these RRSs. MBP–Rep68D bound to the DNA fragmentsserve as an internal control.
containing RRSs at position 018 or at position 0244, but
Electrophoretic mobility-shift assays (EMSAs) not to the fragments containing mRRSs at these positions
(Fig. 2).The EMSAs were performed with the maltose binding
protein fusion proteins MBP–LacZ, MBP–Rep68D, and Rep68 enhances transcription from the HCMV–MIEP
MBP–Rep68DNTP (Chiorini et al., 1994), using the proto- To investigate the effect of Rep68 on transcription
col previously described (Walker et al., 1997; Wonderling from the HCMV – MIEP, we performed cotransfection
and Owens, 1997). MBP–Rep68D is a maltose-binding experiments. Human 293 cells were cotransfected with
protein–Rep68 fusion protein (Chiorini et al., 1994). pCATwt760 and a plasmid encoding either wild-type
MBP–Rep68DNTP is similar to MBP–Rep68D except Rep68 (pSK9) or Repam, a truncated nonfunctional
that it encodes a mutant version of Rep68 with a lysine- amber mutant of Rep68 (pHIVrepamD). Cytoplasmic
to-histidine substitution at amino acid 340 (Chiorini et al., RNA was isolated from the transfected cells 48 hr after
1994). MBP–LacZ is a maltose-binding protein-b galac- transfection and the amount of CAT mRNA was mea-
tosidase fusion protein which served as a negative con- sured using semiquantitative RT-PCR using the prim-
trol (Wonderling et al., 1995). The substrates were four ers shown in Table 1. To our surprise we found that
overlapping regions of the HCMV–MIEP, which were am- Rep68 has the ability to increase expression from the
plified by PCR using PFU DNA polymerase (Stratagene, HCMV – MIEP. As shown in Fig. 4A (pCATwt760 lanes)
La Jolla, CA), radiolabeled forward primers, and unla- and Table 2, we observed a two- to fourfold increase
beled reverse primers (Table 1). The PCR fragments gen- in the steady-state CAT mRNA levels from the HCMV –
erated contained the following stretches of the HCMV – MIEP in cells cotransfected with the plasmid coding
MIEP: Fragment 1 (098 to /7), Fragment 2 (0294 to for Rep68 compared to the cells that were cotrans-070), Fragment 3 (0554 to0270), and Fragment 4 (0749 fected with the plasmid encoding Repam. Similar re-
to 0526). The PCR fragments were purified by electro- sults were observed using Northern blot analysis (data
phoresis on a nondenaturing 4% polyacrylamide gel. not shown). This indicated that Rep68 has the ability
Equal picomoles of each substrate were added to each to enhance transcription from the HCMV – MIEP. These
reaction. results were reproducible with at least two different
preparations of each of the various transfected plas-
RESULTS mids.
HCMV–MIEP does not contain a binding site for Introduction of an RRS into the HCMV-MIEP
Rep68 abrogates the effect of Rep68
We performed sequence analysis to look for an RRS When the Rep68-producing plasmid was cotransfected
with the reporter plasmid carrying an RRS at positionin the HCMV–MIEP. We also performed electrophoretic
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FIG. 2. Electrophoretic mobility shift assays to demonstrate the binding of Rep68 protein to the RRSs introduced into the HCMV–MIEP at positions
018 (A) and 0244 (B). No, L, R, and N denote reactions containing no protein, MBP–LacZ, MBP–Rep68D, and MBP–Rep68DNTP, respectively. B
and F indicate bound and free DNA, respectively. One microgram of protein and 0.04 pmol of the substrate was added to each reaction.
018 (pCAT760/RRS 018), we found that the introduction an RRS in the promoter somehow cancels out this en-
hancement. The presence of the RRS is not strictly posi-of an RRS abrogated the Rep68-induced enhancement
of RNA levels from the HCMV–MIEP (Fig. 4A, RRS018 tion-dependent since even if the RRS is introduced at
position 0244 in the HCMV–MIEP, the effect of Rep68lanes, and Table 2). However, when the same Rep68-
producing plasmid was cotransfected with pCAT760/ was canceled out (Fig. 4A, RRS0244 lanes, and Table
2). Insertion of an mRRS at 0244 resulted in a promotermRRS018, the Rep-mediated increase in RNA levels was
still observed (Fig. 4A, mRRS018 lanes, and Table 2). which could still be enhanced by Rep68 (Fig. 4A,
mRRS0244 lanes, and Table 2). Similar results were ob-These results suggest that Rep68 indirectly enhances
expression from the HCMV–MIEP, and the presence of served using Northern blot analysis (data not shown).
TABLE 1
Descriptions and Sequences of Oligonucleotides
Description Sequence
CAT Forward Primer 5* CCACCGTTGATATATCCCAATGGCA 3*
CAT Reverse Primer 5* GCCAGCGGCATCAGCACCTTGTCGC 3*
CAT-mimic Composite Forward Primer 5* CCACCGTTGATATATCCCAATGGCAGGTTGATTCTGTCCTGGATGTGGTA 3*
CAT-mimic Composite Reverse Primer 5* GCCAGCGGCATCAGCACCTTGTCGCTGGTGTGGTCAGCCTCAGAGTGCGG 3*
Tubulin Forward Primer 5* GGTTGATTCTGTCCTGGATGTGGTA 3*
Tubulin Reverse Primer 5* TGGTGTGGTCAGCCTCAGAGTGCGG 3*
Fragment-1 Forward Primer 5* CTTTCCAAAATGTCGTAACAACTCCG 3*
Fragment-1 Reverse Primer 5* GGATATATCAACGGTGGTATATCCAGTGA 3*
Fragment-2 Forward Primer 5* ATTATGCCCAGTACATGACCTTATG 3*
Fragment-2 Reverse Primer 5* GGCGGAGTTGTTACGACATTTTGGA 3*
Fragment-3 Forward Primer 5* GTCATTAGTTCATAGCCCATATATGGAG 3*
Fragment-3 Reverse Primer 5* CATAAGGTCATGTACTGGGCATAAT 3*
Fragment-4 Forward Primer 5* GATCTATACATTGAATCAATA 3*
Fragment-4 Reverse Primer 5* CTCCATATATGGGCTATGAACTAATGAC 3*
RRS cloned at position 018 5* CGAGTGAGCACGCGAGCT 3*

3* TCGAGCTCACTCGTGCGC 5*
mRRS cloned at position 018 5* GGAGTGAGGACGGGAGCT 3*

3* TCGACCTCACTCCTGCCC 5*
RRS cloned at position 0244 5* GCCCGAGTGAGCACGCAG 3*

3* CGGGCTCACTCGTGCGTC 5*
mRRS cloned at position 0244 5* GCCGGAGTGAGGACGGAG 3*

3* CGGCCTCACTCCTGCCTC 5*
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functions differ from those of adenovirus in that there is
a 24-hr lag period compared to AAV replication in AAV
plus adenovirus coinfections. The expression of HCMV
immediate early genes is essential for the expression of
HCMV early and late genes which ultimately leads to
the production of infectious viral progeny (Stinski, 1990).
Here we report that the AAV Rep68 protein stimulates
expression from the HCMV–MIEP. McPherson et al.FIG. 3. Comparison of the p5 RRS and RRSs introduced into the
(1985) have shown that AAV enhances the cytopathicHCMV–MIEP. The 16-mer core RRS sequence is enclosed in the box.
The bases that are different compared to the p5 RRS are denoted by effect of HCMV. This AAV-mediated increase in the cyto-
lowercase letters. The additional GAGC of HCMV origin present in the pathic effect of HCMV could be due to the enhancement
plasmids pCAT760/RRS-18 and pCAT760/mRRS-18 is underlined. p5 of transcription from the immediate early genes of HCMV
promoter-mRRS-2 is a mutated sequence which was previously demon-
by the Rep proteins of AAV. This suggests that AAV maystrated not to bind Rep68 (Kyo¨stio¨ et al., 1995).
be a modulating factor in the pathogenicity of HCMV
infections in vivo.
Deletion analysis of the HCMV–MIEP
The HCMV–MIEP is one of the strongest promoter/
In an attempt to determine the region of the HCMV – enhancers known. There is an unusually strong enhancer
MIEP that is involved in the Rep-mediated enhance- located between nucleotides 0524 and 0118 of the
ment of transcription, we made a series of deletion HCMV–MIEP (Boshart et al., 1985; Thomsen et al., 1984)
constructs in the promoter region in the reporter plas- (See Fig. 1). There are a number of different repeated
mid pCATwt760. The deletion constructs were cotrans- elements, some of which contain consensus binding
fected with plasmids encoding wild-type Rep68 or Re- sites for known transcription factors (Boshart et al., 1985;
pam. As seen in Fig. 4B and Table 2, deletion of the Stinski, 1990; Stinski and Roehr, 1985; Thomsen et al.,
promoter regulatory regions from0749 to0349 [pCAT/ 1984). DNase I footprinting and in vitro transcription ex-
D(0749 to 0349)] resulted in the elimination of stimu- periments indicate that both repetitive and nonrepetitive
lation by Rep68. However, deletion from 0749 to 0244 sequences in the enhancer may influence downstream
[pCAT/D(0749 to 0244)] showed stimulation by transcription (Depto and Stenberg, 1989; Ghazal et al.,
Rep68. A double deletion, of 0749 to 0244 along with 1987, 1988; Nelson et al., 1990; Thomsen et al., 1984).
018 to /7 [pCAT/D(0749 to 0244/D 018 to /7)], also There is a cluster of NF-1 binding sites (between 0730
showed stimulation by Rep68. Each of the deletions and 0610) and at least one AP1 binding site upstream
also decreased the basal level of CAT mRNA from the from the enhancer (Hennighausen and Fleckenstein,
HCMV – MIEP. 1986; Shelbourn et al., 1989). The HCMV–MIEP also has
a 13-bp cis-repressor signal (crs) located between the
The NTP domain mutant of Rep68 lacks the ability to
TATA box and the transcription start site (from 013 to
enhance transcription from the CMV promoter 01) (Liu et al., 1991). Though the crs functions in either
It has been shown previously (Kyo¨stio¨ et al., 1995) that orientation, it is position-dependent and does not cause
when the RRS in the AAV p5 promoter was mutated to a transcription repression when placed downstream of the
sequence to which Rep68 did not bind in vitro, Rep68 transcription initiation site. The transcription factor YY1
could still partially repress transcription from the p5 pro- has been shown to bind directly to the two 21-bp repeat
moter. However, a mutant Rep protein with a point muta- elements in the HCMV–MIEP (0316 to 0296 and 0509
tion in the NTP-binding motif (Rep68/K340H), which could to 0489) and mediates the repression of HCMV immedi-
partially repress a p5 promoter with a wild-type RRS, com- ate early gene expression in nonpermissive cells (Liu et
pletely lost its ability to repress the p5 promoter when al., 1994). There are also other elements that modulate
the p5-RRS was mutated. This suggested that the effect expression in different cell types (Lubon et al., 1989).
of Rep68 on transcription was partially mediated by the We could not detect the presence of an RRS in the
NTP-binding domain. Therefore, we tested the ability of HCMV–MIEP in spite of the ability of Rep68 to stimulate
the NTP mutant of Rep68 to up-regulate transcription the promoter. A similar phenomenon has been docu-
from the HCMV–MIEP. The results indicated that the mented in a recent report in which the NS1 protein of
NTP mutant was incapable of enhancing transcription minute virus of mice, an autonomous parvovirus, trans-
from the HCMV–MIEP (Fig. 4C), suggesting again the activates the c-erbA-1 gene through a sequence element
involvement of the NTP-binding motif in Rep-mediated devoid of an NS1 binding site (Vanacker et al., 1996). All
transcriptional regulation. this suggests that Rep68 may mediate its effect on the
HCMV–MIEP either by interacting with one or more tran-
DISCUSSION scription factors or by altering the expression of a cellular
gene whose product influences the HCMV–MIEP. In factHCMV has been shown to be a complete helper of
AAV (McPherson et al., 1985). However, HCMV helper it has been recently demonstrated that Rep78 interacts
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with the cellular transcription factor Sp1 (Hermonat et
al., 1996). An Sp1 motif (GGGCGG) is present between
positions 056 and 051 of the HCMV–MIEP (Dynan and
Tjian, 1983; Thomsen et al., 1984).
The ablation of the Rep68-mediated increase in RNA
levels when we insert an RRS into the HCMV–MIEP
could be the net result of both indirect positive effects
and negative regulation mediated by interaction between
Rep68 and the RRS. Pereira et al. (1997) have shown that
Rep proteins can simultaneously function as positive and
negative regulators. Alternatively, the RRS might seques-
ter Rep68 and prevent it from performing its positive regu-
latory functions.
The results from the deletion analysis of the HCMV–
MIEP indicate that the Rep-mediated increase in RNA
levels from the HCMV–MIEP is the result of a complex
interaction which may involve multiple sequence ele-
ments within the promoter. Our data are consistent with
a model in which there are three elements within the
HCMV–MIEP which mediate regulation by Rep68. The
first putative element allows positive regulation and is
located between 0749 and 0349. This region contains
an AP1 binding site, three NF1 binding sites a YY1 bind-
ing site, and several repeated elements within the en-
hancer region (see Fig. 1). The region containing the
AP1 and NF1 sites is missing from the HCMV–MIEP
construct used by Heilbronn et al. (1990), which showed
no stimulation by Rep proteins (their construct contained
0589 to /52). Our construct in which bases 0749 to
0349 are deleted, pCAT/D(0749 to 0349), also shows
no stimulation by Rep68.
The second putative element allows negative regula-
tion by Rep68 and is between 0349 and 0244. This
region is part of the enhancer region and contains a YY1
binding site and several repeated elements. The third
putative element allows positive regulation and is located
between 0244 and 018. When the entire region from
0749 to 0244 is deleted, this leaves only the proximal
positive element which results in constructs whose ex-
pression is stimulated by Rep68. This model could also
explain why one of our deletion mutants, pCAT/D(0749
to 0244), actually appeared to be more highly inducible
than the full-length construct (see Table 2). This construct
lacks the putative negative element, but retains the puta-
tive positive element.
Recent data from Pereira et al. (1997) and Pereira and
D(0749 to 0349), pCAT760/D(0749 to 0244), and pCAT760/D(0749FIG. 4. Rep68 increases RNA levels from the HCMV–MIEP. RT-PCR
assays were done with cytoplasmic RNA isolated from cells cotrans- to 0244/D018 to /7), respectively. Six picograms of RNA was added
per RT-PCR reaction both for detection of CAT and b-tubulin transcripts.fected with various reporter plasmids along with either plasmids encod-
ing Repam (denoted by A), Rep68 (denoted by R), or the NTP binding RT-PCR assays to quantitate CAT messages were done in the presence
of 1 1 10018 mol of CAT-mimic cRNA, which served as an internalsite mutant Rep68/K340H (denoted by N). RRS-18, mRRS-18, RRS-244,
and mRRS-244 indicate cells transfected with the reporter plasmids control for the RT and PCR steps. Cell nuclei were processed and
blotted as described under Materials and Methods and probed with apCAT760/RRS-18, pCAT760/mRRS-18, pCAT760/RRS-244, and pCAT760/
mRRS-244, respectively. D-349, D-244, and D-244/D-18 to /7 rep- CAT-probe to estimate the amount of reporter plasmid taken up by the
cells. A, B, and C show different gels.resent cells transfected with the reporter plasmids pCAT760/
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TABLE 2 case activity of the Rep proteins is involved in gene regu-
lation (Wonderling et al., 1995).Summary of the Effect of Rep68 on the CAT mRNA Levels
The Rep68-mediated increase in transcription from thefrom the HCMV-MIEP
HCMV–MIEP in 293 cells that we report here is in con-
Rep-mediated fold trast to earlier observations of others who did not see
increase in mRNA such an increase (Heilbronn et al., 1990; Rittner et al.,Reporter plasmid levels { std. dev. P valuea
1992). The reason for this could be because the cells
used by these investigators were of different origin (hu-pCATwt760 2.8 { 0.9 0.01b
pCAT760/RRS-18 1.2 { 0.1 0.07 man epithelioid SW480 cells and hamster Elona 11 cells).
pCAT760/mRRS-18 2.5 { 1.0 0.03 There are modulator regions in the HCMV–MIEP that are
pCAT760/RRS-244 1.3 { 0.2 0.13
cell-specific (Lubon et al., 1989) which could contribute topCAT760/mRRS-244 2.0 { 0.1 0.04
this difference. Moreover, the length of the HCMV–MIEPpCAT/D(0749 to 0349) 1.5 { 0.2 0.12
pCAT/D(0749 to 0244) 4.1 { 0.6 0.002 that was used by Heilbronn et al. (1990) was different
pCAT/D(0749 to 0244/ (0598 to /52) compared to the one used in our study
D018 to /7) 2.2 { 0.2 0.03 (0749 to /7). In addition, in these reports the effect of
Rep on the HCMV–MIEP was measured by CAT assaysa P value (probability that such a difference could occur by chance
in contrast to our report wherein we looked at CAT mRNAif there was no stimulation by Rep68) obtained from one-tailed Student’s
t Test. levels. Trempe and Carter (1988) have shown that the
b P value  0.05 is not considered significant (a value  0.05). effects of Rep proteins on CAT activity can be different
from their effects on CAT mRNA levels from the same
plasmids, presumably due to an effect on translation. The
Muzyczka (1997a and b) also suggest that Rep78 and/or previous studies used a rep gene with the endogenous
Rep68 can simultaneously function as an activator p5 promoter which is strongly down-regulated by Rep
through the binding site in the AAV terminal repeat, as proteins (Heilbronn et al., 1990; Kyo¨stio¨ et al., 1995). We
a repressor through the binding site in the AAV p5 pro- on the other hand use the HIV-LTR promoter to express
moter, and as an activator via an interaction with Sp1 the rep gene, which results in Rep protein levels compa-
bound to the p19 promoter. Our shortest deletion con- rable to the high levels seen in the presence of helper
struct, pCAT/D(0749 to 0244/D018 to /7), shows stim- virus infection (Owens et al., 1993). Our results are also
ulation by Rep68 and still contains an Sp1 binding site
consistent with the previous observation that coinfection
(056 to 051).
with AAV enhances the cytopathic effect of HCMV in
Such a complex system of both positive and negative
human embryonic fibroblasts (McPherson et al., 1985).
regulatory elements might suggest that the Rep pro-
HCMV is a suspected cofactor in graft atherosclerosisteins of AAV have evolved to finely control the level of
and restenosis in humans (Grattan et al., 1989; Zhougene expression from the helper virus, HCMV. It should
et al., 1996). In a rat model system for CMV-inducedbe noted that an AAV rep gene appears to have been
atherosclerosis, CMV infection induces expression of theincorporated into the genome of another herpesvirus,
genes which encode the B polypeptide of platelet-de-human herpesvirus type 6 (HHV-6) (Thomson et al.,
rived growth factor (PDGF) and transforming growth fac-1991). It is intriguing to speculate that the product of
tor-b1 (Lemstro¨m et al., 1994). Induction of these genesthis gene is used to modulate HHV-6 gene expression.
is believed to contribute to the development of athero-Thomson et al. (1994) have already shown that the
sclerotic plaques (Lemstro¨m et al., 1994). Interestingly,product of the HHV-6 rep gene can positively regulate
we have recently demonstrated that the AAV Rep68 pro-the HIV-LTR promoter and that HHV-6 does function
tein also induces expression of the gene which encodesas a helper virus for AAV.
the B polypeptide of PDGF in human cells (WonderlingThe fact that the NTP-domain mutant of Rep68 lacked
and Owens, 1996). Since HCMV is a helper for AAV (Mc-the ability to enhance transcription suggests a role for
Pherson et al., 1985), it is likely that coinfection is athe NTP-binding motif in this Rep-mediated regulation.
common occurrence in nature. Lynch et al. (1997) haveMcCarty et al. (1992) demonstrated that mutation of this
shown that recombinant AAV vectors can transduce hu-same region (T341I, N342Y) resulted in Rep proteins
man vascular endothelial and smooth muscle cells. It iswhich could no longer transactivate the AAV p40 promoter
therefore probable that these cells can be infected byin the presence of an adenovirus infection. Kyo¨stio¨ et
wild-type AAV. Grossman et al. (1992) have detected AAVal. (1995) have also demonstrated previously that ATP
DNA in the peripheral blood leukocytes of healthy humanincreases binding of Rep68 to the p5-RRS. It is therefore
blood donors. It is therefore intriguing to speculate thatpossible that Rep undergoes a change upon binding or
AAV may also be a contributing factor for atherosclerosis,hydrolysis of ATP, which makes it suitable to interact
both by Rep68 stimulation of this PDGF gene and bywith other transcriptional regulators. It is also possible
that the ATP-dependent DNA helicase or RNA/DNA heli- enhancing expression from the HCMV–MIEP.
AID VY 8724 / 6a41$$$363 08-15-97 10:13:21 vira AP: VY
175AAV Rep68 STIMULATES THE HCMV PROMOTER
Hermonat, P. L. (1989). The adeno-associated virus Rep78 gene inhibitsACKNOWLEDGMENTS
cellular transformation induced by bovine papillomavirus. Virology
We thank Jeffery Miller and Nancy Nossal for critically reviewing the 172, 253–261.
manuscript. Hermonat, P. L. (1991). Inhibition of H-ras expression by the adeno-
associated virus Rep78 transformation suppressor gene product.
Cancer Res. 51, 3373–3377.REFERENCES
Hermonat, P. L. (1994). Down-regulation of the human c-fos and c-myc
proto-oncogene promoters by adeno-associated virus Rep78. CancerAntoni, B. A., Rabson, A. B., Miller, I. L., Trempe, J. P., Chejanovsky, N.,
Lett. 81, 129–136.and Carter, B. J. (1991). Adeno-associated virus Rep protein inhibits
Hermonat, P. L., Labow, M. A., Wright, R., Berns, K. I., and Muzyczka, N.human immunodeficiency virus type 1 production in human cells. J.
(1984). Genetics of adeno-associated virus: isolation and preliminaryVirol. 65, 396–404.
characterization of adeno-associated virus type 2 mutants. J. Virol.Batchu, R. B., and Hermonat, P. L. (1995). The trans-inhibitory Rep78
51, 329–339.protein of adeno-associated virus binds to TAR region DNA of the
human immunodeficiency virus type 1 long terminal repeat. FEBS Hermonat, P. L., Santin, A. D., and Batchu, R. B. (1996). The adeno-
associated virus Rep78 major regulatory/transformation suppressorLett. 367, 267–271.
Batchu, R. B., Kotin, R. M., and Hermonat, P. L. (1994). The regulatory protein binds cellular Sp1 in vitro and evidence of a biological effect.
Cancer Res. 56, 5299–5304.rep protein of adeno-associated virus binds to sequences within the
c-H-ras promoter. Cancer Lett. 86, 23–31. Ho¨rer, M., Weger, S., Butz, K., Hoppe-Seyler, F., Geisen, C., and
Beaton, A., Palumbo, P., and Berns, K. I. (1989). Expression from the Kleinschmidt, J. A. (1995). Mutational analysis of adeno-associated
adeno-associated virus p5 and p19 promoters is negatively regulated virus Rep protein-mediated inhibition of heterologous and homolo-
in trans by the rep protein. J. Virol. 63, 4450–4454. gous promoters. J. Virol. 69, 5485–5496.
Boshart, M., Weber, F., Jahn, G., Dorsch-Ha¨sler, K., Fleckenstein, B., Im, D. S., and Muzyczka, N. (1990). The AAV origin binding protein
and Schaffner, W. (1985). A very strong enhancer is located upstream Rep68 is an ATP-dependent site-specific endonuclease with DNA
of an immediate early gene of human cytomegalovirus. Cell 41, 521– helicase activity. Cell 61, 447–457.
530. Im, D. S., and Muzyczka, N. (1992). Partial purification of adeno-associ-
Carter, B. J. (1990). Adeno-associated virus helper functions. In ‘‘Hand- ated virus Rep78, Rep52, and Rep40 and their biochemical character-
book of Parvoviruses’’ (P. Tijssen, Ed.), pp. 255–282. CRC Press, ization. J. Virol. 66, 1119–1128.
Boca Raton, FL. Khleif, S. N., Myers, T., Carter, B. J., and Trempe, J. P. (1991). Inhibition
Carter, B. J., Trempe, J. P., and Mendelson, E. (1990). Adeno-associated of cellular transformation by the adeno-associated virus rep gene.
virus gene expression and regulation. In ‘‘Handbook of parvoviruses’’ Virology 181, 738–741.
(P. Tijssen, Ed.), pp. 227–254. CRC Press, Boca Raton, FL. Kotin, R. M., Siniscalco, M., Samulski, R. J., Zhu, X., Hunter, L., Laughlin,
Chiorini, J. A., Weitzman, M. D., Owens, R. A., Urcelay, E., Safer, B., C. A., McLaughlin, S., Muzyczka, N., Rocchi, M., and Berns, K. I.
and Kotin, R. M. (1994). Biologically active Rep proteins of adeno- (1990). Site-specific integration by adeno-associated virus. Proc. Natl.
associated virus type 2 produced as fusion proteins in Escherichia Acad. Sci. USA 87, 2211–2215.
coli. J. Virol. 68, 797–804. Ku¨hn, J. E., Wendland, T., Eggers, H. J., Lorentzen, E., Wieland, U., Eing,
Depto, A. S., and Stenberg, R. M. (1989). Regulated expression of the B., Kiessling, M., and Gass, P. (1995). Quantitation of human cytomeg-
human cytomegalovirus pp65 gene: Octamer sequence in the pro- alovirus genomes in the brain of AIDS patients. J. Med. Virol. 47, 70–
moter is required for activation by viral gene products. J. Virol. 63, 82.
1232–1238. Kyo¨stio¨, S. R. M., Owens, R. A., Weitzman, M. D., Antoni, B. A., Chejanov-
Dynan, W. S., and Tjian, R. (1983). The promoter-specific transcription sky, N., and Carter, B. J. (1994). Analysis of adeno-associated virus
factor Sp1 binds to upstream sequences in the SV40 early promoter. (AAV) wild-type and mutant Rep proteins for their abilities to nega-
Cell 35, 79–87. tively regulate AAV p5 and p19 mRNA levels. J. Virol. 68, 2947–2957.
Ghazal, P., Lubon, H., Fleckenstein, B., and Hennighausen, L. (1987).
Kyo¨stio¨, S. R. M., Wonderling, R. S., and Owens, R. A. (1995). Negative
Binding of transcription factors and creation of a large nucleoprotein
regulation of the adeno-associated virus (AAV) P5 promoter involvescomplex on the human cytomegalovirus enhancer. Proc. Natl. Acad.
both the P5 Rep binding site and the consensus ATP-binding motifSci. USA 84, 3658–3662.
of the AAV Rep68 protein. J. Virol. 69, 6787–6796.
Ghazal, P., Lubon, H., and Hennighausen, L. (1988). Specific interac-
Labow, M. A., Hermonat, P. L., and Berns, K. I. (1986). Positive andtions between transcription factors and the promoter-regulatory re-
negative autoregulation of the adeno-associated virus type 2 ge-gion of the human cytomegalovirus major immediate-early gene. J.
nome. J. Virol. 60, 251–258.Virol. 62, 1076–1079.
Lemstro¨m, K. B., Aho, P. T., Bruggeman, C. A., and Ha¨yry, P. J. (1994).Graham, F. L., Smiley, J., Russell, W. C., and Nairn, R. (1977). Character-
Cytomegalovirus infection enhances mRNA expression of platelet-istics of a human cell line transformed by DNA from human adenovi-
derived growth factor-BB and transforming growth factor-b1 in ratrus type 5. J. Gen. Virol. 36, 59–72.
aortic allografts. Arterioscler. Thromb. 14, 2043–2052.Grattan, M. T., Moreno-Cabral, C. E., Starnes, V. A., Oyer, P. E., Stinson,
Linden, R. M., Winocour, E.,and Berns, K. I. (1996). The recombinationE. B., and Shumway, N. E. (1989). Cytomegalovirus infection is asso-
signals for adeno-associated virus site-specific integration. Proc.ciated with cardiac allograft rejection and atherosclerosis. J. Am.
Natl. Acad. Sci. USA 93, 7966–7972.Med. Assoc. 261, 3561–3566.
Liu, B., Hermiston, T. W., and Stinski, M. F. (1991). A cis-acting elementGrossman, Z., Mendelson, E., Brok-Simoni, F., Mileguir, F., Leitner, Y.,
in the major immediate-early (IE) promoter of human cytomegalovirusRechavi, G., and Ramot, B. (1992). Detection of adeno-associated
is required for negative regulation by IE2. J. Virol. 65, 897–903.virus type 2 in human peripheral blood cells. J. Gen. Virol. 73, 961–
Liu, R., Baillie, J., Sissons, J. G. P., and Sinclair, J. H. (1994). The tran-966.
scription factor YY1 binds to negative regulatory elements in theHeilbronn, R., Bu¨rkle, A., Stephan, S., and zur Hausen, H. (1990). The
human cytomegalovirus major immediate early enhancer/promoteradeno-associated virus rep gene suppresses herpes simplex virus-
and mediates repression in non-permissive cells. Nucleic Acids Res.induced DNA amplification. J. Virol. 64, 3012–3018.
22, 2453–2459.Hennighausen, L., and Fleckenstein, B. (1986). Nuclear factor 1 inter-
Lubon, H., Ghazal, P., Hennighausen, L., Reynolds-Kohler, C., Lockshin,acts with five DNA elements in the promoter region of the human
cytomegalovirus major immediate early gene. EMBO J. 5, 1367–1371. C., and Nelson, J. (1989). Cell-specific activity of the modulator region
AID VY 8724 / 6a41$$$364 08-15-97 10:13:21 vira AP: VY
176 WONDERLING ET AL.
in the human cytomegalovirus major immediate-early gene. Mol. Cell. quence and organization of the adeno-associated virus 2 genome.
J. Virol. 45, 555–564.Biol. 9, 1342–1345.
Lynch, C. M., Hara, P. S., Leonard, J. C., Williams, J. K., Dean, R. H., and Stagno, S., Pass, R. F., Dworsky, M. E., Henderson, R. E., Moore, E. G.,
Walton, P. D., and Alford, C. A. (1982). Congenital cytomegalovirusGeary, R. L. (1997). Adeno-associated virus vectors for vascular gene
delivery. Circ. Res. 80, 497– 505. infection: The relative importance of primary and recurrent maternal
infection. N. Engl. J. Med. 306, 945–949.McCarty, D. M., Christensen, M., and Muzyczka, N. (1991). Sequences
required for coordinate induction of adeno-associated virus p19 and Stinski, M. F. (1990). Cytomegalovirus and its replication. In ‘‘Virology’’
(B. N. Fields and D. M. Knipe, Eds.), 2nd ed., pp. 1959–1980. Ravenp40 promoters by Rep protein. J. Virol. 65, 2936–2945.
McCarty, D. M., Ni, T. H., and Muzyczka, N. (1992). Analysis of mutations Press, New York.
Stinski, M. F., and Roehr, T. J. (1985). Activation of the major immediatein adeno-associated virus Rep protein in vivo and in vitro. J. Virol.
66, 4050–4057. early gene of human cytomegalovirus by cis-acting elements in the
promoter-regulatory sequence and by virus-specific trans-actingMcCarty, D. M., Pereira, D. J., Zolotukhin, I., Zhou, X., Ryan, J. H., and
Muzyczka, N. (1994). Identification of linear DNA sequences that components. J. Virol. 55, 431–441.
Thomsen, D. R., Stenberg, R. M., Goins, W. F., and Stinski, M. F. (1984).specifically bind the adeno-associated virus Rep protein. J. Virol. 68,
4988–4997. Promoter-regulatory region of the major immediate early gene of
human cytomegalovirus. Proc. Natl. Acad. Sci. USA 81, 659–663.McPherson, R. A., Rosenthal, L. J., and Rose, J. A. (1985). Human cyto-
megalovirus completely helps adeno-associated virus replication. Vi- Thomson, B. J., Efstathiou, S., and Honess, R. W. (1991). Acquisition
of the human adeno-associated virus type-2 rep gene by humanrology 147, 217–222.
Mendelson, E., Trempe, J. P., and Carter, B. J. (1986). Identification of the herpesvirus type-6. Nature 351, 78–80.
Thomson, B. J., Weindler, F. W., Gray, D., Schwaab, V., and Heilbronn,trans-acting Rep proteins of adeno-associated virus by antibodies to
a synthetic oligopeptide. J. Virol. 60, 823–832. R. (1994). Human herpesvirus 6 (HHV-6) is a helper virus for adeno-
associated virus type 2 (AAV-2) and the AAV-2 rep gene homologueNelson, J. A., Gnann, Jr., J. W., and Ghazal, P. (1990). Regulation and
tissue-specific expression of human cytomegalovirus. Curr. Top. Mi- in HHV-6 can mediate AAV-2 DNA replication and regulate gene
expression. Virology 204, 304–311.crobiol. Immunol. 154, 75–100.
Oelze, I., Rittner, K., and Sczakiel, G. (1994). Adeno-associated virus Trempe, J. P., and Carter, B. J. (1988). Regulation of adeno-associated
virus gene expression in 293 cells: Control of mRNA abundance andtype 2 rep gene-mediated inhibition of basal gene expression of
human immunodeficiency virus type 1 involves its negative regulatory translation. J. Virol. 62, 68–74.
Urcelay, E., Ward, P., Wiener, S. M., Safer, B., and Kotin, R. M. (1995). Asym-functions. J. Virol. 68, 1229– 1233.
Owens, R. A., Weitzman, M. D., Kyo¨stio¨, S. R. M., and Carter, B. J. (1993). metric replication in vitro from a human sequence element is dependent
on adeno-associated virus Rep protein. J. Virol. 69, 2038–2046.Identification of a DNA-binding domain in the amino terminus of
adeno-associated virus Rep proteins. J. Virol. 67, 997–1005. Vanacker, J.-M., Corbau, R., Adelmant, G., Perros, M., Laudet, V., and
Rommelaere, J. (1996). Transactivation of a cellular promoter by thePereira, D. J., McCarty, D. M., and Muzyczka, N. (1997). The adeno-
associated virus (AAV) Rep protein acts as both a repressor and an NS1 protein of the parvovirus minute virus of mice through a putative
hormone-responsive element. J. Virol. 70, 2369–2377.activator to regulate AAV transcription during a productive infection.
J. Virol. 71, 1079–1088. Walker, S. L., Wonderling, R. S., and Owens, R. A. (1997). Mutational
analysis of the adeno-associated virus Rep68 protein: IdentificationPereira, D. J., and Muzyczka, N. (1997a). The cellular transcription factor
SP1 and an unknown cellular protein are required to mediate Rep of critical residues necessary for site-specific endonuclease activity.
J. Virol. 71, 2722–2730.protein activation of the adeno-associated virus p19 promoter. J. Virol.
71, 1747–1756. Weitzman, M. D., Kyo¨stio¨, S. R. M., Kotin, R. M., and Owens, R. A. (1994).
Adeno-associated virus (AAV) Rep proteins mediate complex forma-Pereira, D. J., and Muzyczka, N. (1997b). The adeno-associated virus type
2 p40 promoter requires a proximal Sp1 interaction and a p19 CArG- tion between AAV DNA and its integration site in human DNA. Proc.
Natl. Acad. Sci. USA 91, 5808–5812.like element to facilitate Rep transactivation. J. Virol. 71, 4300–4309.
Ratnamohan, V. M., Mathy¨s, J. M., McKenzie, A., and Cunningham, A. L. Weller, T. H. (1971). The cytomegaloviruses: Ubiquitous agents with pro-
tean clinical manifestations. N. Engl. J. Med. 285, 203–214; 267–274.(1992). HCMV-DNA is detected more frequently than infectious virus
in blood leucocytes of immunocompromised patients: A direct com- Wigler, M., Pellicer, A., Silverstein, S., and Axel, R. (1978). Biochemical
transfer of single-copy eucaryotic genes using total cellular DNA asparison of culture-immunofluorescence and PCR for detection of
HCMV in clinical specimens. J. Med. Virol. 38, 252–259. donor. Cell 14, 725–731.
Wonderling, R. S., Kyo¨stio¨, S. R. M., and Owens, R. A. (1995). A maltose-Rittner, K., Heilbronn, R., Kleinschmidt, J. A., and Sczakiel, G. (1992). Adeno-
associated virus type 2-mediated inhibition of human immunodeficiency binding protein/adeno-associated virus Rep68 fusion protein has
DNA-RNA helicase and ATPase activities. J. Virol. 69, 3542–3548.virus type 1 (HIV-1) replication: involvement of p78rep/p68rep and the HIV-
1 long terminal repeat. J. Gen. Virol. 73, 2977–2981. Wonderling, R. S., and Owens, R. A. (1996). The Rep68 protein of adeno-
associated virus type 2 stimulates expression of the platelet-derivedSambrook, J., Fritsch, E. F., and Maniatis, T. (1989). ‘‘Molecular Cloning:
A Laboratory Manual,’’ 2nd ed. Cold Spring Harbor Laboratory Press, growth factor B c-sis proto-oncogene. J. Virol. 70, 4783–4786.
Wonderling, R. S., and Owens, R. A. (1997). Binding sites for adeno-Cold Spring Harbor, NY.
Shelbourn, S. L., Kothari, S. K., Sissons, J. G. P., and Sinclair, J. H. (1989). associated virus Rep proteins within the human genome. J. Virol. 71,
2528–2534.Repression of human cytomegalovirus gene expression associated
with a novel immediate early regulatory region binding factor. Nucleic Zaia, J. A. (1986). The biology of human cytomegalovirus infection after
bone marrow transplantation. Int. J. Cell Cloning 4(Suppl. 1), 135–154.Acids Res. 17, 9165–9171.
Snyder, R. O., Im, D. S., and Muzyczka, N. (1990). Evidence for covalent Zhou, Y., F., Leon, M. B., Waclawiw, M. A., Popma, J.J., Yu, Z. X., Finkel,
T., and Epstein, S. E. (1996). Association between prior cytomegalovi-attachment of the adeno-associated virus (AAV) Rep protein to the
ends of the AAV genome. J. Virol. 64, 6204–6213. rus infection and the risk of restenosis after coronary atherectomy.
N. Engl. J. Med. 335, 624–630.Srivastava, A., Lusby, E. W., and Berns, K. I. (1983). Nucleotide se-
AID VY 8724 / 6a41$$$364 08-15-97 10:13:21 vira AP: VY
